| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.07 (Beat by $0.02528) |
| EPS GAAP Actual | $0.07 (Beat by $0.02528) |
| Revenue Actual | $1.60528B |
| Revenue Surprise | Beat by $1605.28M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.17286 |
| EPS GAAP Estimate | $0.17286 |
| Revenue Estimate | $1.64723521B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.99 | 16.83 | 0.89325 | 1.044 | 1 |
| Dec 2027 | 1.2 | 13.89 | 1.14855 | 1.27658 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.06 | -0.22365 | 1.60528B | 59.7% | 14.55M |
| FQ2 2025 (Jun 2025) | -0.01 | -0.01 | 1.29621B | 11.33% | 1296.21M |
| FQ1 2025 (Mar 2025) | -0.07 | -0.07 | 1.03726B | -11.43% | 1037.26M |
| FQ4 2024 (Dec 2024) | 4.81 | 4.81 | 1.76941B | 51.72% | 1769.41M |
| FQ3 2024 (Sep 2024) | -3.62 | -3.62 | 0.646948B | -80.05% | 646.95M |
| FQ2 2024 (Jun 2024) | 0.0093 | 0.0093 | 1.14941B | -4.22% | 1149.41M |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 1.15585B | 45.69% | 1155.85M |
| FQ4 2023 (Dec 2023) | -0.0054 | -0.0054 | 0.854251B | 43.72% | 854.25M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.17286
Consensus Revenue Estimates
1.64723521B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26922 | -- | 0.23332 | 0.29728 | 1 |
| FQ3 2027 (Sep 2027) | 0.3019 | -- | 0.28145 | 0.32701 | 3 |
| FQ2 2027 (Jun 2027) | 0.2825 | -- | 0.26337 | 0.30599 | 5 |
| FQ1 2027 (Mar 2027) | 0.21969 | -- | 0.21104 | 0.22393 | 7 |
| FQ4 2026 (Oct 2026) | 0.23077 | -- | 0.20922 | 0.2599 | 3 |
| FQ3 2026 (Jul 2026) | 0.22291 | 126.92 | 0.2021 | 0.25104 | 3 |
| FQ2 2026 (Jun 2026) | 0.19514 | 105.12 | 0.17068 | 0.22784 | 4 |
| FQ1 2026 (Mar 2026) | 0.11366 | 161.59 | 0.09941051 | 0.13271 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.14B | -- | 1.92B | 2.31B | 2 |
| FQ3 2027 (Sep 2027) | 1.65B | -- | 1.56B | 1.76B | 2 |
| FQ2 2027 (Jun 2027) | 1.66B | -- | 1.57B | 1.77B | 2 |
| FQ1 2027 (Mar 2027) | 1.78B | -- | 1.73B | 1.81B | 2 |
| FQ4 2026 (Oct 2026) | 1.86B | -- | 1.73B | 2.04B | 4 |
| FQ3 2026 (Jul 2026) | 1.86B | 13.57 | 1.72B | 2.04B | 6 |
| FQ2 2026 (Jun 2026) | 1.76B | 26.35 | 1.59B | 1.99B | 6 |
| FQ1 2026 (Mar 2026) | 1.53B | 32.3 | 1.38B | 1.73B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16365 | -0.06 | -0.22365 | 372.75% |
| FQ2 2025 (Jun 2025) | -0.01 | -0.01 | 100% | |
| FQ1 2025 (Mar 2025) | -0.07 | -0.07 | 100% | |
| FQ4 2024 (Dec 2024) | 4.81 | 4.81 | 100% | |
| FQ3 2024 (Sep 2024) | -3.62 | -3.62 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0093 | 0.0093 | 100% | |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0054 | -0.0054 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.59B | $1.61B | $14.55M | 0.91% |
| FQ2 2025 (Jun 2025) | $0B | $1.3B | $1296.21M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.04B | $1037.26M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.77B | $1769.41M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.65B | $646.95M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.15B | $1149.41M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.16B | $1155.85M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.85B | $854.25M | 100% |